Poland· PL-100371466
Calgel
A sonstige buccale therapeutika product containing lidocaini hydrochloridum + cetylpyridinii chloridum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sonstige buccale therapeutika is registered in 7 of 19 countries.
Countries holding a registration under ATC A01AD11 (sonstige buccale therapeutika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Sonstige buccale therapeutika · ATC A01AD11
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Lidocaini hydrochloridum + Cetylpyridinii chloridum
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- A01AD11
- ATC class
- Sonstige buccale Therapeutika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991279424
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sonstige buccale therapeutika in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBonjela Junior gelReckitt Benckiser Healthcare (UK) Ltd
- SwitzerlandMebucaïne N, LutschtablettenSpirig HealthCare AG
- CzechiaCALGELMcNeil Healthcare (Ireland) Limited, Dublin
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Bulgaria · Калгел
- Czechia · Calgel
- Estonia · Calgel
- United Kingdom (Northern Ireland) · Bonjela Junior, Calgel Teething
- Greece · Xylojell Plus
- Hungary · Mebucain Mint
- Latvia · Calgel
- Romania · Calgel
- Slovenia · Calgel
- Slovakia · Calgel, Oroforte Menthol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9b4a7c3f-5c22-4bc7-bc99-1bab19e6e852 GET /v1/drugs/9b4a7c3f-5c22-4bc7-bc99-1bab19e6e852?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Żel do stosowania na dziąsła",
"source": "urpl",
"strength": "(3,3 mg + 1 mg)/g",
"packaging": "05909991279424 ¦ OTC ¦ 116177\n1 tuba 10 g",
"substance": "Lidocaini hydrochloridum 3.3 mg/g + Cetylpyridinii chloridum 1 mg/g",
"common_name": "Lidocaini hydrochloridum + Cetylpyridinii chloridum",
"pl_product_id": "100371466",
"pozwolenie_nr": "296/16",
"auth_procedure": "IR",
"authorisation_validity": "2031-05-31"
}See everything about sonstige buccale therapeutika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.